Sieve Health

Executive Summary

Sieve Health is a San Francisco-based digital health company that leverages artificial intelligence and machine learning to transform clinical trial recruitment and operations. Founded in 2020, the company addresses critical bottlenecks in drug development, including site burnout, inefficient feasibility analysis, and patient matching. By automating trial feasibility, site selection, and participant identification, Sieve Health aims to accelerate timelines, enhance participant diversity, and support decentralized trial models. The platform is designed to reduce administrative burdens on clinical sites, enabling faster and more inclusive studies. As clinical trials increasingly adopt technology-driven solutions, Sieve Health is well-positioned to capture market share in the growing digital health and AI diagnostics space. Although the company is private and has not disclosed funding or valuation details, its focus on high-impact operational efficiency and alignment with industry trends suggests strong potential for growth and adoption.

Upcoming Catalysts (preview)

• Q3 2026Series A Funding Announcement70% success
• Q4 2026Major Pharma Partnership for Platform Integration50% success
• Q1 2027Launch of New AI-Powered Patient Recruitment Module80% success